Search

everythinglearnresearchcommunity

for

Search:↓

Dexamethasone affects hair growth by altering levels of proteins that either promote or inhibit hair follicle growth.

Dexamethasone increases androgen receptor activity in scalp cells, which might explain stress-related hair loss.

17β-estradiol may help hair growth by increasing cannabinoid receptor type 1.

Activating CB1 can reduce keratin levels, potentially helping manage psoriasis and aid wound healing.

Activating cannabinoid receptor 1 may help manage psoriasis by reducing certain keratins.

Two new compounds can block androgen receptor activity in different ways and may lead to new treatments for androgen-related diseases.

Estrogen affects hair growth and skin cell multiplication.

Estradiol stops hair growth in mice, but an antagonist can reverse this effect.

Spironolactone may help reduce COVID-19 severity in men by blocking harmful effects of certain hormones.

Blocking DHT production more strongly may help control advanced prostate cancer and improve quality of life.

Bisphenol-A (BPA) increases connections between brain cells and boosts their activity, but it blocks the effects of a male hormone on brain cell plasticity.

New steroids were effective in blocking male hormone receptors in hamster prostates.

Merremia peltata leaf extract, particularly the bufotalinin compound, shows potential for treating hair loss.

Clascoterone 1% cream is a promising new treatment for acne.

Certain histamine receptors (H2R, H3R, H4R) have unique roles in treating skin diseases, with H2R helping with chronic urticaria and other conditions, H3R providing pain relief and allergy benefits, and H4R reducing inflammation and itchiness.

PPARs help regulate skin health and could be used to treat skin disorders.

LPA3 is crucial for embryo implantation and links LPA to prostaglandin signaling.

Blocking Wnt/β-catenin signaling with EGF receptor is necessary for proper hair growth.

17β-estradiol lowers polyamine oxidase levels in breast cancer cells through estrogen receptor 2.

Blocking a protein called prostaglandin D2 might help treat hair loss.

Estrogen receptor α controls hair growth cycles and skin thickness in male mice.

Blocking EGFR can cause skin inflammation by disrupting IL-1 signaling.

The new anti-acne treatment HA-P5 effectively reduces acne by targeting two key receptors and avoids an enzyme that can hinder treatment.

Prostaglandin E2 promotes skin cancer, but certain supplements and drugs may help reduce risk and improve treatment.

Prolactin affects hair growth and skin conditions, and could be a target for new skin disease treatments.

A natural steroid in the body may protect against eye damage in glaucoma.

Treatments for PCOS aim to reduce androgen levels and improve insulin sensitivity to lower cardiometabolic risk.

Spironolactone successfully treated hair loss in a 9-year-old girl.

New treatments for chronic central serous chorioretinopathy show promise in preventing permanent vision loss.

The document concludes that treating androgen excess needs patience, managing expectations is important, and many drugs used are not officially approved, suggesting cosmetic options for mild cases.